CD40LG and myeloid sarcoma: Regardless of the growth factor source, a comparative analysis of OPC/RR-MS CD49d+CD154+ lymphocyte coculture confirmed the unique properties of MS lymphocytes in modifying the environment of remyelinating plaque.